Valk PJM - Search Results

1

Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.

Grob T, Al Hinai ASA, Sanders MA, Kavelaars FG, Rijken M, Gradowska PL, Biemond BJ, Breems DA, Maertens J, van Marwijk Kooy M, Pabst T, de Weerdt O, Ossenkoppele GJ, van de Loosdrecht AA, Huls GA, Cornelissen JJ, Beverloo HB, Löwenberg B, Jongen-Lavrencic M, Valk PJM. Grob T, et al. Among authors: valk pjm. Blood. 2022 Apr 14;139(15):2347-2354. doi: 10.1182/blood.2021014472. Blood. 2022. PMID: 35108372 Free PMC article.

2

Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells.

Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Löwenberg B, Delwel R. Valk P, et al. Blood. 1997 Aug 15;90(4):1448-57. Blood. 1997. PMID: 9269762 Free article.

3

A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites.

Valk PJ, Joosten M, Vankan Y, Löwenberg B, Delwel R. Valk PJ, et al. Nucleic Acids Res. 1997 Nov 1;25(21):4419-21. doi: 10.1093/nar/25.21.4419. Nucleic Acids Res. 1997. PMID: 9336478 Free PMC article.

4

Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.

Valk PJ, Vankan Y, Joosten M, Jenkins NA, Copeland NG, Löwenberg B, Delwel R. Valk PJ, et al. J Virol. 1999 May;73(5):3595-602. doi: 10.1128/JVI.73.5.3595-3602.1999. J Virol. 1999. PMID: 10196250 Free PMC article.

5

Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.

Joosten M, Valk PJ, Vankan Y, de Both N, Löwenberg B, Delwel R. Joosten M, et al. Virology. 2000 Mar 15;268(2):308-18. doi: 10.1006/viro.2000.0183. Virology. 2000. PMID: 10704339 Free article.

6

Leukemic predisposition of pSca-1/Cb2 transgenic mice.

Joosten M, Valk PJ, Jordà MA, Vankan-Berkhoudt Y, Verbakel S, van den Broek M, Beijen A, Löwenberg B, Delwel R. Joosten M, et al. Exp Hematol. 2002 Feb;30(2):142-9. doi: 10.1016/s0301-472x(01)00779-2. Exp Hematol. 2002. PMID: 11823049 Free article.

7

Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2.

Valk P, Verbakel S, von Lindern M, Löwenberg B, Delwel R. Valk P, et al. Hematol J. 2000;1(4):254-63. doi: 10.1038/sj.thj.6200036. Hematol J. 2000. PMID: 11920199

8

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol.

Jordà MA, Verbakel SE, Valk PJ, Vankan-Berkhoudt YV, Maccarrone M, Finazzi-Agrò A, Löwenberg B, Delwel R. Jordà MA, et al. Blood. 2002 Apr 15;99(8):2786-93. doi: 10.1182/blood.v99.8.2786. Blood. 2002. PMID: 11929767 Free article.

9

Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.

van der Reijden BA, Simons A, Luiten E, van der Poel SC, Hogenbirk PE, Tönnissen E, Valk PJ, Löwenberg B, De Greef GE, Breuning MH, Jansen JH. van der Reijden BA, et al. Br J Haematol. 2002 Aug;118(2):411-8. doi: 10.1046/j.1365-2141.2002.03738.x. Br J Haematol. 2002. PMID: 12139724 Free article.

10

Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites.

Joosten M, Vankan-Berkhoudt Y, Tas M, Lunghi M, Jenniskens Y, Parganas E, Valk PJ, Löwenberg B, van den Akker E, Delwel R. Joosten M, et al. Oncogene. 2002 Oct 17;21(47):7247-55. doi: 10.1038/sj.onc.1205813. Oncogene. 2002. PMID: 12370816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page